Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Eight weeks of androgen priming by hCG before IVF/ICSI in women with low ovarian reserve

X
Trial Profile

Eight weeks of androgen priming by hCG before IVF/ICSI in women with low ovarian reserve

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Apr 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Choriogonadotropin alfa (Primary) ; Ganirelix; Recombinant follicle-stimulating hormone
  • Indications Female infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Apr 2023 Primary endpoint has not been met. (Follicular output rate (FORT) = the proportion of the antral follicle count that reach the pre-ovulatory stage.), as per Results published in the Human Reproduction
    • 03 Apr 2023 Results published in the Human Reproduction
    • 24 Aug 2022 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top